eltoprazine
Small moleculeexperimental
Eltoprazine is a serotonergic drug of the phenylpiperazine class which is described as a serenic, or anti-aggressive agent. — Wikipedia
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2011 (NCT01266174)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
HTR1B agonist
HTR1A agonist
- Serotonin 2c (5-HT2c) receptorANTAGONIST
HTR2C antagonist
Chemistry & pharmacology
Loading structure…
SMILES
c1cc2c(c(N3CCNCC3)c1)OCCO2- Mol. weight
- 220.27 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaEltoprazine ↗
- ChEMBLCHEMBL282614 ↗
Also known as
- 1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazine
- du 28853
- du-28853
- du-28853
- du-28853
- eltoprazine
- eltoprazine
- eltoprazine
- eltoprazine
- eltoprazine
- eltoprazine hydrochloride
- eltoprazine hydrochloride
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02439125 | Phase 2 | May 1, 2015 | Amarantus BioScience Holdings, Inc. |
| NCT01266174 | Phase 2 | Aug 1, 2011 | Amarantus BioScience Holdings, Inc., Northwestern University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Amarantus BioScience Holdings, Inc. | For profit | 2 | 2 | 1 | 2011 |
| Northwestern University | Academic/Hospital | 1 | 0 | 1 | 2011 |
2 organizations
Page 1 / 1